Class information for: |
Basic class information |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
| Cluster id | Level | Cluster label | #P |
|---|---|---|---|
| 10 | 4 | IMMUNOLOGY//TRANSPLANTATION//RHEUMATOLOGY | 1369268 |
| 125 | 3 | RHEUMATOLOGY//RHEUMATOID ARTHRITIS//RHEUMATOL | 69344 |
| 3084 | 2 | METHOTREXATE//7 HYDROXYMETHOTREXATE//METHOTREXATE POLYGLUTAMATES | 2546 |
| 15949 | 1 | HIGH DOSE METHOTREXATE//7 HYDROXYMETHOTREXATE//GLUCARPIDASE | 709 |
Terms with highest relevance score |
| rank | Category | termType | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
|---|---|---|---|---|---|---|
| 1 | HIGH DOSE METHOTREXATE | authKW | 656868 | 6% | 34% | 44 |
| 2 | 7 HYDROXYMETHOTREXATE | authKW | 646071 | 4% | 58% | 25 |
| 3 | GLUCARPIDASE | authKW | 448214 | 2% | 92% | 11 |
| 4 | METHOTREXATE | authKW | 422315 | 32% | 4% | 229 |
| 5 | CARBOXYPEPTIDASE G2 | authKW | 256231 | 2% | 41% | 14 |
| 6 | METHOTREXATE TOXICITY | authKW | 173489 | 2% | 35% | 11 |
| 7 | 2 4 DIAMINO N 10 METHYLPTEROIC ACID | authKW | 88902 | 0% | 100% | 2 |
| 8 | DAMPA | authKW | 88902 | 0% | 100% | 2 |
| 9 | ELIMINATION DELAY | authKW | 88902 | 0% | 100% | 2 |
| 10 | LD METHOTREXATE | authKW | 88902 | 0% | 100% | 2 |
Web of Science journal categories |
| chi_square_rank | Category | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
|---|---|---|---|---|---|
| 1 | Oncology | 3786 | 39% | 0% | 273 |
| 2 | Pharmacology & Pharmacy | 2139 | 33% | 0% | 234 |
| 3 | Medical Laboratory Technology | 1070 | 7% | 0% | 47 |
| 4 | Chemistry, Analytical | 1037 | 17% | 0% | 124 |
| 5 | Hematology | 992 | 12% | 0% | 85 |
| 6 | Pediatrics | 603 | 11% | 0% | 77 |
| 7 | Biochemical Research Methods | 292 | 8% | 0% | 54 |
| 8 | Toxicology | 73 | 4% | 0% | 27 |
| 9 | Electrochemistry | 29 | 2% | 0% | 17 |
| 10 | Medicine, Research & Experimental | 12 | 3% | 0% | 20 |
Address terms |
| chi_square_rank | term | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
|---|---|---|---|---|---|
| 1 | PHARM PHARMACOKINET THER EUT DRUG MONITOR | 88902 | 0% | 100% | 2 |
| 2 | ANALYSE CHIM BIOL MED | 44451 | 0% | 100% | 1 |
| 3 | ANALYT MOL TOXICOL | 44451 | 0% | 100% | 1 |
| 4 | BIOMED CHEM NEOLEK RUDOLFA WEIGLA 12 | 44451 | 0% | 100% | 1 |
| 5 | CHEM BIOMOL NANOTECHNOL NQB | 44451 | 0% | 100% | 1 |
| 6 | CHEM SCI BIOCHEM DIAGNOST | 44451 | 0% | 100% | 1 |
| 7 | CHILEAN PEDIAT ONCOL GRP | 44451 | 0% | 100% | 1 |
| 8 | CHIM VERTE CATALYSE CGCC CCVC | 44451 | 0% | 100% | 1 |
| 9 | CLIN PHARMACOKINET PHARMACODYNAM SECT | 44451 | 0% | 100% | 1 |
| 10 | CLIN PHARMACOL ROOM PHARM | 44451 | 0% | 100% | 1 |
Journals |
| chi_square_rank | term | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
|---|---|---|---|---|---|
| 1 | CANCER CHEMOTHERAPY AND PHARMACOLOGY | 17271 | 8% | 1% | 54 |
| 2 | PEDIATRIC HEMATOLOGY AND ONCOLOGY | 11476 | 3% | 1% | 23 |
| 3 | CANCER DRUG DELIVERY | 6123 | 1% | 3% | 4 |
| 4 | THERAPEUTIC DRUG MONITORING | 5146 | 3% | 1% | 21 |
| 5 | CANCER TREATMENT REPORTS | 4516 | 2% | 1% | 15 |
| 6 | JOURNAL OF ONCOLOGY PHARMACY PRACTICE | 4061 | 1% | 2% | 5 |
| 7 | PEDIATRIC BLOOD & CANCER | 2666 | 2% | 0% | 17 |
| 8 | JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES | 1273 | 3% | 0% | 19 |
| 9 | JOURNAL OF PHARMACOKINETICS AND BIOPHARMACEUTICS | 960 | 1% | 1% | 4 |
| 10 | JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY | 940 | 1% | 0% | 9 |
Author Key Words |
| chi_square_rank | term | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass | LCSH search | Wikipedia search |
|---|---|---|---|---|---|---|---|
| 1 | HIGH DOSE METHOTREXATE | 656868 | 6% | 34% | 44 | Search HIGH+DOSE+METHOTREXATE | Search HIGH+DOSE+METHOTREXATE |
| 2 | 7 HYDROXYMETHOTREXATE | 646071 | 4% | 58% | 25 | Search 7+HYDROXYMETHOTREXATE | Search 7+HYDROXYMETHOTREXATE |
| 3 | GLUCARPIDASE | 448214 | 2% | 92% | 11 | Search GLUCARPIDASE | Search GLUCARPIDASE |
| 4 | METHOTREXATE | 422315 | 32% | 4% | 229 | Search METHOTREXATE | Search METHOTREXATE |
| 5 | CARBOXYPEPTIDASE G2 | 256231 | 2% | 41% | 14 | Search CARBOXYPEPTIDASE+G2 | Search CARBOXYPEPTIDASE+G2 |
| 6 | METHOTREXATE TOXICITY | 173489 | 2% | 35% | 11 | Search METHOTREXATE+TOXICITY | Search METHOTREXATE+TOXICITY |
| 7 | 2 4 DIAMINO N 10 METHYLPTEROIC ACID | 88902 | 0% | 100% | 2 | Search 2+4+DIAMINO+N+10+METHYLPTEROIC+ACID | Search 2+4+DIAMINO+N+10+METHYLPTEROIC+ACID |
| 8 | DAMPA | 88902 | 0% | 100% | 2 | Search DAMPA | Search DAMPA |
| 9 | ELIMINATION DELAY | 88902 | 0% | 100% | 2 | Search ELIMINATION+DELAY | Search ELIMINATION+DELAY |
| 10 | LD METHOTREXATE | 88902 | 0% | 100% | 2 | Search LD+METHOTREXATE | Search LD+METHOTREXATE |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Classes with closest relation at Level 1 |